Dantrolene sodium in children with spasticity.
D000284:Administration, Oral; D000293:Adolescent; D001925:Brain Damage, Chronic / Q000150:complications; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D003620:Dantrolene / Q000008:administration & dosage / Q000627:therapeutic use; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D006827:Hydantoins / Q000627:therapeutic use*; D007223:Infant; D008297:Male; D009125:Muscle Relaxants, Central / Q000627:therapeutic use; D009207:Myoclonus / Q000188:drug therapy; D010919:Placebos; D013035:Spasm / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D013223:Statistics as Topic
D006827:Hydantoins; D009125:Muscle Relaxants, Central; D010919:Placebos; D003620:Dantrolene